Your browser doesn't support javascript.
loading
Do We Still Need 5α-Reductase Inhibitors for Patients with Benign Prostatic Hyperplasia After the PARTEM Study?
Bilhim, Tiago.
Affiliation
  • Bilhim T; Consultant Interventional Radiologist, Interventional Radiology Unit, Centro Hospitalar Universitário de Lisboa Central (CHULC), Lisbon, Portugal. tiagobilhim@hotmail.com.
Cardiovasc Intervent Radiol ; 46(10): 1428-1429, 2023 10.
Article in En | MEDLINE | ID: mdl-37553447
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / 5-alpha Reductase Inhibitors Limits: Humans / Male Language: En Journal: Cardiovasc Intervent Radiol Year: 2023 Document type: Article Affiliation country: Portugal
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / 5-alpha Reductase Inhibitors Limits: Humans / Male Language: En Journal: Cardiovasc Intervent Radiol Year: 2023 Document type: Article Affiliation country: Portugal